The drug pricing debate is top of mind with manufacturers, payers, governments, patients, and the medical professionals who treat them. In this issue of CRA Insights: Life Sciences we examine some of these issues.
Charles River Associates announces six VP promotions
Charles River Associates today announced the promotions of six new vice presidents. Sean Sheridan in CRA’s Intellectual Property Practice, Eddie Li, Erika...